GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NantHealth Inc (OTCPK:NHIQ) » Definitions » EV-to-EBIT

NantHealth (NantHealth) EV-to-EBIT : -5.85 (As of May. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is NantHealth EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, NantHealth's Enterprise Value is $310.64 Mil. NantHealth's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-53.13 Mil. Therefore, NantHealth's EV-to-EBIT for today is -5.85.

The historical rank and industry rank for NantHealth's EV-to-EBIT or its related term are showing as below:

NHIQ' s EV-to-EBIT Range Over the Past 10 Years
Min: -34.48   Med: -5.7   Max: -1.36
Current: -5.85

During the past 9 years, the highest EV-to-EBIT of NantHealth was -1.36. The lowest was -34.48. And the median was -5.70.

NHIQ's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.53 vs NHIQ: -5.85

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. NantHealth's Enterprise Value for the quarter that ended in Sep. 2023 was $282.54 Mil. NantHealth's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-53.13 Mil. NantHealth's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -18.80%.


NantHealth EV-to-EBIT Historical Data

The historical data trend for NantHealth's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NantHealth EV-to-EBIT Chart

NantHealth Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only -1.37 -6.75 -8.14 -7.99 -5.44

NantHealth Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.37 -5.44 -5.83 -5.35 -5.32

Competitive Comparison of NantHealth's EV-to-EBIT

For the Health Information Services subindustry, NantHealth's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NantHealth's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NantHealth's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NantHealth's EV-to-EBIT falls into.



NantHealth EV-to-EBIT Calculation

NantHealth's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=310.641/-53.13
=-5.85

NantHealth's current Enterprise Value is $310.64 Mil.
NantHealth's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-53.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NantHealth  (OTCPK:NHIQ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

NantHealth's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-53.13/282.5382451
=-18.80 %

NantHealth's Enterprise Value for the quarter that ended in Sep. 2023 was $282.54 Mil.
NantHealth's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-53.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NantHealth EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of NantHealth's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


NantHealth (NantHealth) Business Description

Traded in Other Exchanges
N/A
Address
3000 RDU Center Drive, Suite 200, Morrisville, NC, USA, 27500
NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision-making. The company provides cancer care solutions, provide solutions, and payer solutions.
Executives
Rao Haris Naseem director, 10 percent owner, officer: Chief Executive Officer C/O NANTHEALTH, INC., 760 W. FIRE TOWER RD., SUITE 107, WINTERVILLE NC 28590
Summus Holdings Llc 10 percent owner 2871 LAKE VISTA DR, SUITE 210, LEWISVILLE TX 75067
Ronald Allen Louks officer: Chief Operating Officer C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Nant Capital, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Patrick Soon-shiong director, 10 percent owner, officer: See Remarks 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Deanna L. Wise director C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD, CULVER CITY CA 90232
Bob Petrou officer: Interim CFO C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Mp 13 Ventures, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Cambridge Equities, Lp 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Allscripts Healthcare Solutions, Inc. 10 percent owner 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Nantworks, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Investment Office Kuwait 10 percent owner 15 CARTER LANE, LONDON X0 EC4V 5EY
Miller Edward D Jr director JOHNS HOPKINS, 733 NORTH BROADWAY - SUITE 100, BALTIMORE MD 21205
Kuwait Investment Authority On Behalf Of The Govt Of Kuwait 10 percent owner C/O HOMEPLACE OF AMERICA INC, 3200 POTTERY DRIVE, MYRTLE BEACH SC 29579
James Mark Burnett director 640 N. SEPULVEDA BLVD., LOS ANGELES CA 90049

NantHealth (NantHealth) Headlines

From GuruFocus

Nanthealth Inc (NH) CEO Patrick Soon-shiong Bought $5 million of Shares

By GuruFocus Research GuruFocus Editor 04-16-2021